Karuna Therapeutics Inc (NASDAQ:KRTX)

Delayed Data
As of Jun 09
 -6.21 / -2.66%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Karuna Therapeutics Inc have a median target of 272.00, with a high estimate of 334.00 and a low estimate of 193.00. The median estimate represents a +19.50% increase from the last price of 227.61.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Buy stock in Karuna Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.52%
Growthannually -33.79%


Growthquarterly -44.22%
Growthannually -59.53%
Key to the earnings and sales forecast charts.